Global and China Next Generation Cancer Diagnostics Industry Market Research Report (2017-2028)

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • This report elaborates on the current development of the Next Generation Cancer Diagnostics industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.

    Competitive Landscape:

    • Janssen Global Services

    • Qiagen

    • Sysmex Corporation

    • F Hoffmann-La Roche Ltd

    • Koninklijke Philips NV

    • Agilent Technologies

    • Abbott

    • Cepheid

    • Opko Health

    • Thermo Fisher Scientific

    • Almac Group

    • Novartis AG

    • Hologic

    • Illumina

    • Genomic Health

    • Myriad Genetics

    • GE Healthcare

    • PerkinElmer

    Region:

    • China

    • North America

    • Europe

    • APAC

    • Latin America, Middle East and Africa

    Type:

    • Next Generation Sequencing

    • qPCR & Multiplexing

    • DNA Microarrays

    • Others

    Application:

    • Hospitals

    • Clinics

    • Others

  • Table of Content

    Chapter 1 Industry Overview & Development Status in Global and China Market

    • 1.1 Next Generation Cancer Diagnostics Industry Overview

      • 1.1.1 Next Generation Cancer Diagnostics Market Scope and Market Segments

      • 1.1.2 Next Generation Cancer Diagnostics Industry Characteristics

      • 1.1.3 Global and China Next Generation Cancer Diagnostics Sales Volume and Growth Rate (2017-2028)

      • 1.1.4 Global and China Next Generation Cancer Diagnostics Production Value and Growth Rate (2017-2028)

    • 1.2 Global Next Generation Cancer Diagnostics Market Size and Growth Rate by Type (2017-2028)

      • 1.2.1 Next Generation Sequencing

      • 1.2.2 qPCR & Multiplexing

      • 1.2.3 DNA Microarrays

      • 1.2.4 Others

    • 1.3 Global Next Generation Cancer Diagnostics Market Size and Growth Rate by Application (2017-2028)

      • 1.3.1 Hospitals

      • 1.3.2 Clinics

      • 1.3.3 Others

    • 1.4 Market Analysis by Region

      • 1.4.1 North America Next Generation Cancer Diagnostics Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.2 Europe Next Generation Cancer Diagnostics Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.3 APAC Next Generation Cancer Diagnostics Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.4 Latin America, Middle East and Africa Next Generation Cancer Diagnostics Consumption Market Size and Growth Rate (2017-2028)

    • 1.5 Global Next Generation Cancer Diagnostics Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

      • 1.5.1 Global Next Generation Cancer Diagnostics Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • 1.6 China Next Generation Cancer Diagnostics Sales Volume, Price, Sales Value (2017-2028)

      • 1.6.1 China Next Generation Cancer Diagnostics Sales Volume, Price, Sales Value (2017-2028)

    Chapter 2 Global Next Generation Cancer Diagnostics Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Challenges and Restraints

      • 2.1.2 Opportunities and Potentialities

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape

      • 2.2.1 Market Concentration Rate Analysis

      • 2.2.2 Next Generation Cancer Diagnostics Industry Porter's Five Forces Model Analysis

      • 2.2.3 Next Generation Cancer Diagnostics Industry PEST Analysis

    • 2.3 Next Generation Cancer Diagnostics Industry Chain Analysis

      • 2.3.1 Raw Material Supplies

      • 2.3.2 Next Generation Cancer Diagnostics Downstream Market Analysis

      • 2.3.3 Upstream and Downstream Impacts on Next Generation Cancer Diagnostics Industry

    Chapter 3 Global and China Next Generation Cancer Diagnostics Market, by Manufacturer

    • 3.1 Global and China Next Generation Cancer Diagnostics Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)

      • 3.1.1 Global and China Next Generation Cancer Diagnostics Sales Volume, by Manufacturer (2021&2022)

      • 3.1.2 Global and China Next Generation Cancer Diagnostics Sales Value, by Manufacturer (2021&2022)

      • 3.1.3 Global and China Next Generation Cancer Diagnostics Market Share, by Manufacturer (2021&2022)

    • 3.2 SWOT Analysis on Global and China Next Generation Cancer Diagnostics Market Top 3 Players

    Chapter 4 Global and China Next Generation Cancer Diagnostics Market, by Type (2017-2028)

    • 4.1 Next Generation Cancer Diagnostics Market Trend, by Type

    • 4.2 Global Next Generation Cancer Diagnostics Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.2.1 Global Next Generation Cancer Diagnostics Sales Volume and Market Share, by Type (2017-2028)

      • 4.2.2 Global Next Generation Cancer Diagnostics Sales Value and Market Share, by Type (2017-2028)

      • 4.2.3 Global Next Generation Cancer Diagnostics Price Trend, by Type (2017-2028)

    • 4.3 China Next Generation Cancer Diagnostics Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.3.1 China Next Generation Cancer Diagnostics Sales Volume and Market Share, by Type (2017-2028)

      • 4.3.2 China Next Generation Cancer Diagnostics Sales Value and Market Share, by Type (2017-2028)

      • 4.3.3 China Next Generation Cancer Diagnostics Price Trend, by Type (2017-2028)

    Chapter 5 Global and China Next Generation Cancer Diagnostics Market, by Application (2017-2028)

    • 5.1 Downstream Market Overview

    • 5.2 Global Next Generation Cancer Diagnostics Sales Volume, Sales Value and Market Share, by Application

      • 5.2.1 Global Next Generation Cancer Diagnostics Sales Volume and Market Share, by Application (2017-2028)

      • 5.2.2 Global Next Generation Cancer Diagnostics Sales Value and Market Share, by Application (2017-2028)

    • 5.3 China Next Generation Cancer Diagnostics Sales Volume, Sales Value and Market Share, by Application

      • 5.3.1 China Next Generation Cancer Diagnostics Sales Volume and Market Share, by Application (2017-2028)

      • 5.3.2 China Next Generation Cancer Diagnostics Sales Value and Market Share, by Application (2017-2028)

    Chapter 6 Global Next Generation Cancer Diagnostics Production, Import, Consumption and Export, by Region (2017-2022)

    • 6.1 China Next Generation Cancer Diagnostics Production, Import, Consumption and Export (2017-2022)

    • 6.2 North America Next Generation Cancer Diagnostics Production, Import, Consumption and Export (2017-2022)

    • 6.3 Europe Next Generation Cancer Diagnostics Production, Import, Consumption and Export (2017-2022)

    • 6.4 APAC Next Generation Cancer Diagnostics Production, Import, Consumption and Export (2017-2022)

    • 6.5 Latin America, Middle East and Africa Next Generation Cancer Diagnostics Production, Import, Consumption and Export (2017-2022)

    Chapter 7 North America Next Generation Cancer Diagnostics Market Analysis

    • 7.1 North America Next Generation Cancer Diagnostics Market, by Type

    • 7.2 North America Next Generation Cancer Diagnostics Market, by Application

    • 7.3 North America Next Generation Cancer Diagnostics Market Analysis and Forecast, by Country

      • 7.3.1 United States Next Generation Cancer Diagnostics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.2 Canada Next Generation Cancer Diagnostics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.3 Mexico Next Generation Cancer Diagnostics Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 8 Europe Next Generation Cancer Diagnostics Market Analysis

    • 8.1 Europe Next Generation Cancer Diagnostics Market, by Type

    • 8.2 Europe Next Generation Cancer Diagnostics Market, by Application

    • 8.3 Europe Next Generation Cancer Diagnostics Market Analysis and Forecast, by Country

      • 8.3.1 Germany Next Generation Cancer Diagnostics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.2 UK Next Generation Cancer Diagnostics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.3 France Next Generation Cancer Diagnostics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.4 Italy Next Generation Cancer Diagnostics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.5 Nordic Countries Next Generation Cancer Diagnostics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.6 Spain Next Generation Cancer Diagnostics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.7 Belgium Next Generation Cancer Diagnostics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.8 Poland Next Generation Cancer Diagnostics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.9 Russia Next Generation Cancer Diagnostics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.10 Turkey Next Generation Cancer Diagnostics Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 9 APAC Next Generation Cancer Diagnostics Market Analysis

    • 9.1 APAC Next Generation Cancer Diagnostics Market, by Type

    • 9.2 APAC Next Generation Cancer Diagnostics Market, by Application

    • 9.3 APAC Next Generation Cancer Diagnostics Market Analysis and Forecast, by Country

      • 9.3.1 China Next Generation Cancer Diagnostics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.2 Japan Next Generation Cancer Diagnostics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.3 Australia and New Zealand Next Generation Cancer Diagnostics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.4 India Next Generation Cancer Diagnostics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.5 ASEAN Countries Next Generation Cancer Diagnostics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.6 South Korea Next Generation Cancer Diagnostics Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 10 Latin America, Middle East and Africa Next Generation Cancer Diagnostics Market Analysis

    • 10.1 Latin America, Middle East and Africa Next Generation Cancer Diagnostics Market, by Type

    • 10.2 Latin America, Middle East and Africa Next Generation Cancer Diagnostics Market, by Application

    • 10.3 Latin America, Middle East and Africa Next Generation Cancer Diagnostics Market Analysis and Forecast, by Country

      • 10.3.1 GCC Countries Next Generation Cancer Diagnostics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.2 Brazil Next Generation Cancer Diagnostics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.3 Nigeria Next Generation Cancer Diagnostics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.4 South Africa Next Generation Cancer Diagnostics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.5 Argentina Next Generation Cancer Diagnostics Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 11 Global and China Next Generation Cancer Diagnostics Company Profiles

      • 11.1 Janssen Global Services

        • 11.1.1 Janssen Global Services Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.1.2 Janssen Global Services Next Generation Cancer Diagnostics Product Profiles, Application and Specification

        • 11.1.3 Janssen Global Services Next Generation Cancer Diagnostics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.2 Qiagen

        • 11.2.1 Qiagen Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.2.2 Qiagen Next Generation Cancer Diagnostics Product Profiles, Application and Specification

        • 11.2.3 Qiagen Next Generation Cancer Diagnostics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.3 Sysmex Corporation

        • 11.3.1 Sysmex Corporation Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.3.2 Sysmex Corporation Next Generation Cancer Diagnostics Product Profiles, Application and Specification

        • 11.3.3 Sysmex Corporation Next Generation Cancer Diagnostics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.4 F Hoffmann-La Roche Ltd

        • 11.4.1 F Hoffmann-La Roche Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.4.2 F Hoffmann-La Roche Ltd Next Generation Cancer Diagnostics Product Profiles, Application and Specification

        • 11.4.3 F Hoffmann-La Roche Ltd Next Generation Cancer Diagnostics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.5 Koninklijke Philips NV

        • 11.5.1 Koninklijke Philips NV Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.5.2 Koninklijke Philips NV Next Generation Cancer Diagnostics Product Profiles, Application and Specification

        • 11.5.3 Koninklijke Philips NV Next Generation Cancer Diagnostics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.6 Agilent Technologies

        • 11.6.1 Agilent Technologies Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.6.2 Agilent Technologies Next Generation Cancer Diagnostics Product Profiles, Application and Specification

        • 11.6.3 Agilent Technologies Next Generation Cancer Diagnostics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.7 Abbott

        • 11.7.1 Abbott Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.7.2 Abbott Next Generation Cancer Diagnostics Product Profiles, Application and Specification

        • 11.7.3 Abbott Next Generation Cancer Diagnostics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.8 Cepheid

        • 11.8.1 Cepheid Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.8.2 Cepheid Next Generation Cancer Diagnostics Product Profiles, Application and Specification

        • 11.8.3 Cepheid Next Generation Cancer Diagnostics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.9 Opko Health

        • 11.9.1 Opko Health Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.9.2 Opko Health Next Generation Cancer Diagnostics Product Profiles, Application and Specification

        • 11.9.3 Opko Health Next Generation Cancer Diagnostics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.10 Thermo Fisher Scientific

        • 11.10.1 Thermo Fisher Scientific Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.10.2 Thermo Fisher Scientific Next Generation Cancer Diagnostics Product Profiles, Application and Specification

        • 11.10.3 Thermo Fisher Scientific Next Generation Cancer Diagnostics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.11 Almac Group

        • 11.11.1 Almac Group Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.11.2 Almac Group Next Generation Cancer Diagnostics Product Profiles, Application and Specification

        • 11.11.3 Almac Group Next Generation Cancer Diagnostics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.12 Novartis AG

        • 11.12.1 Novartis AG Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.12.2 Novartis AG Next Generation Cancer Diagnostics Product Profiles, Application and Specification

        • 11.12.3 Novartis AG Next Generation Cancer Diagnostics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.13 Hologic

        • 11.13.1 Hologic Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.13.2 Hologic Next Generation Cancer Diagnostics Product Profiles, Application and Specification

        • 11.13.3 Hologic Next Generation Cancer Diagnostics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.14 Illumina

        • 11.14.1 Illumina Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.14.2 Illumina Next Generation Cancer Diagnostics Product Profiles, Application and Specification

        • 11.14.3 Illumina Next Generation Cancer Diagnostics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.15 Genomic Health

        • 11.15.1 Genomic Health Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.15.2 Genomic Health Next Generation Cancer Diagnostics Product Profiles, Application and Specification

        • 11.15.3 Genomic Health Next Generation Cancer Diagnostics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.16 Myriad Genetics

        • 11.16.1 Myriad Genetics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.16.2 Myriad Genetics Next Generation Cancer Diagnostics Product Profiles, Application and Specification

        • 11.16.3 Myriad Genetics Next Generation Cancer Diagnostics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.17 GE Healthcare

        • 11.17.1 GE Healthcare Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.17.2 GE Healthcare Next Generation Cancer Diagnostics Product Profiles, Application and Specification

        • 11.17.3 GE Healthcare Next Generation Cancer Diagnostics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.18 PerkinElmer

        • 11.18.1 PerkinElmer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.18.2 PerkinElmer Next Generation Cancer Diagnostics Product Profiles, Application and Specification

        • 11.18.3 PerkinElmer Next Generation Cancer Diagnostics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    Chapter 12 Next Generation Cancer Diagnostics Industry Investment Prospect and Risk Assessment

    • 12.1 Next Generation Cancer Diagnostics Industry Investment Prospect Assessment

      • 12.1.1 Investment Opportunities in Segmented Markets

      • 12.1.2 Investment Opportunities in Regional Markets

      • 12.1.3 Investment Opportunities in Subdivided Industries

    • 12.2 Next Generation Cancer Diagnostics Industry Investment Risk Assessment

      • 12.2.1 Competitive Risk Analysis

      • 12.2.2 Technology Risk Analysis

      • 12.2.3 Policies and Enterprise System Risk Analysis

    List of Tables and Figures

    • Figure Global Next Generation Cancer Diagnostics Sales Volume and Growth Rate (2017-2028)

    • Figure China Next Generation Cancer Diagnostics Sales Volume and Growth Rate (2017-2028)

    • Figure Global Next Generation Cancer Diagnostics Production Value and Growth Rate (2017-2028)

    • Figure China Next Generation Cancer Diagnostics Production Value and Growth Rate (2017-2028)

    • Figure Global Next Generation Cancer Diagnostics Market Size and Growth Rate of Next Generation Sequencing (2017-2028)

    • Figure Global Next Generation Cancer Diagnostics Market Size and Growth Rate of qPCR & Multiplexing (2017-2028)

    • Figure Global Next Generation Cancer Diagnostics Market Size and Growth Rate of DNA Microarrays (2017-2028)

    • Figure Global Next Generation Cancer Diagnostics Market Size and Growth Rate of Others (2017-2028)

    • Figure Global Next Generation Cancer Diagnostics Market Size and Growth Rate of Hospitals (2017-2028)

    • Figure Global Next Generation Cancer Diagnostics Market Size and Growth Rate of Clinics (2017-2028)

    • Figure Global Next Generation Cancer Diagnostics Market Size and Growth Rate of Others (2017-2028)

    • Figure North America Next Generation Cancer Diagnostics Consumption Market Size and Growth Rate (2017-2028)

    • Figure Europe Next Generation Cancer Diagnostics Consumption Market Size and Growth Rate (2017-2028)

    • Figure APAC Next Generation Cancer Diagnostics Consumption Market Size and Growth Rate (2017-2028)

    • Figure Latin America, Middle East and Africa Next Generation Cancer Diagnostics Consumption Market Size and Growth Rate (2017-2028)

    • Figure Global Next Generation Cancer Diagnostics Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • Figure China Next Generation Cancer Diagnostics Sales Volume, Price, Sales Value (2017-2028)

    • Figure Porter's Five Forces Model Analysis

    • Figure Industry PEST Analysis

    • Table Global and China Next Generation Cancer Diagnostics Sales Volume, by Manufacturer (2021&2022)

    • Table Global and China Next Generation Cancer Diagnostics Sales Value, by Manufacturer (2021&2022)

    • Table Global and China Next Generation Cancer Diagnostics Market Share, by Manufacturer (2021&2022)

    • Figure Global and China Next Generation Cancer Diagnostics Market Share, by Manufacturer in 2021

    • Figure Global and China Next Generation Cancer Diagnostics Market Share, by Manufacturer in 2022

    • Table Global Next Generation Cancer Diagnostics Sales Volume, by Type (2017-2028)

    • Table Global Next Generation Cancer Diagnostics Sales Volume Share, by Type (2017-2028)

    • Figure Global Next Generation Cancer Diagnostics Sales Volume Share, by Type (2017-2028)

    • Table Global Next Generation Cancer Diagnostics Sales Value, by Type (2017-2028)

    • Table Global Next Generation Cancer Diagnostics Sales Value Share, by Type (2017-2028)

    • Figure Global Next Generation Cancer Diagnostics Price Trend, by Type (2017-2028)

    • Table China Next Generation Cancer Diagnostics Sales Volume, by Type (2017-2028)

    • Table China Next Generation Cancer Diagnostics Sales Volume Share, by Type (2017-2028)

    • Figure China Next Generation Cancer Diagnostics Sales Volume Share, by Type (2017-2028)

    • Table China Next Generation Cancer Diagnostics Sales Value, by Type (2017-2028)

    • Table China Next Generation Cancer Diagnostics Sales Value Share, by Type (2017-2028)

    • Figure China Next Generation Cancer Diagnostics Price Trend, by Type (2017-2028)

    • Table Global Next Generation Cancer Diagnostics Sales Volume, by Application (2017-2028)

    • Table Global Next Generation Cancer Diagnostics Sales Volume Share, by Application (2017-2028)

    • Figure Global Next Generation Cancer Diagnostics Sales Volume Share, by Application (2017-2028)

    • Table Global Next Generation Cancer Diagnostics Sales Value, by Application (2017-2028)

    • Table Global Next Generation Cancer Diagnostics Sales Value Share, by Application (2017-2028)

    • Figure Global Next Generation Cancer Diagnostics Sales Value Share, by Application (2017-2028)

    • Table China Next Generation Cancer Diagnostics Sales Volume, by Application (2017-2028)

    • Table China Next Generation Cancer Diagnostics Sales Volume Share, by Application (2017-2028)

    • Figure China Next Generation Cancer Diagnostics Sales Volume Share, by Application (2017-2028)

    • Table China Next Generation Cancer Diagnostics Sales Value, by Application (2017-2028)

    • Table China Next Generation Cancer Diagnostics Sales Value Share, by Application (2017-2028)

    • Figure China Next Generation Cancer Diagnostics Sales Value Share, by Application (2017-2028)

    • Figure China Next Generation Cancer Diagnostics Production, Import, Consumption and Export (2017-2022)

    • Figure North America Next Generation Cancer Diagnostics Production, Import, Consumption and Export (2017-2022)

    • Figure Europe Next Generation Cancer Diagnostics Production, Import, Consumption and Export (2017-2022)

    • Figure APAC Next Generation Cancer Diagnostics Production, Import, Consumption and Export (2017-2022)

    • Figure Latin America, Middle East and Africa Next Generation Cancer Diagnostics Production, Import, Consumption and Export (2017-2022)

    • Table North America Next Generation Cancer Diagnostics Sales Volume, by Type (2017-2028)

    • Table North America Next Generation Cancer Diagnostics Sales Volume Share, by Type (2017-2028)

    • Figure North America Next Generation Cancer Diagnostics Sales Volume Share, by Type (2017-2028)

    • Table North America Next Generation Cancer Diagnostics Sales Volume, by Application (2017-2028)

    • Table North America Next Generation Cancer Diagnostics Sales Volume Share, by Application (2017-2028)

    • Figure North America Next Generation Cancer Diagnostics Sales Volume Share, by Application (2017-2028)

    • Figure United States Next Generation Cancer Diagnostics Sales Volume and Growth Rate (2017-2028)

    • Figure United States Next Generation Cancer Diagnostics Sales Value and Growth Rate (2017-2028)

    • Figure Canada Next Generation Cancer Diagnostics Sales Volume and Growth Rate (2017-2028)

    • Figure Canada Next Generation Cancer Diagnostics Sales Value and Growth Rate (2017-2028)

    • Figure Mexico Next Generation Cancer Diagnostics Sales Volume and Growth Rate (2017-2028)

    • Figure Mexico Next Generation Cancer Diagnostics Sales Value and Growth Rate (2017-2028)

    • Table Europe Next Generation Cancer Diagnostics Sales Volume, by Type (2017-2028)

    • Table Europe Next Generation Cancer Diagnostics Sales Volume Share, by Type (2017-2028)

    • Figure Europe Next Generation Cancer Diagnostics Sales Volume Share, by Type (2017-2028)

    • Table Europe Next Generation Cancer Diagnostics Sales Volume, by Application (2017-2028)

    • Table Europe Next Generation Cancer Diagnostics Sales Volume Share, by Application (2017-2028)

    • Figure Europe Next Generation Cancer Diagnostics Sales Volume Share, by Application (2017-2028)

    • Figure Germany Next Generation Cancer Diagnostics Sales Volume and Growth Rate (2017-2028)

    • Figure Germany Next Generation Cancer Diagnostics Sales Value and Growth Rate (2017-2028)

    • Figure UK Next Generation Cancer Diagnostics Sales Volume and Growth Rate (2017-2028)

    • Figure UK Next Generation Cancer Diagnostics Sales Value and Growth Rate (2017-2028)

    • Figure France Next Generation Cancer Diagnostics Sales Volume and Growth Rate (2017-2028)

    • Figure France Next Generation Cancer Diagnostics Sales Value and Growth Rate (2017-2028)

    • Figure Italy Next Generation Cancer Diagnostics Sales Volume and Growth Rate (2017-2028)

    • Figure Italy Next Generation Cancer Diagnostics Sales Value and Growth Rate (2017-2028)

    • Figure Nordic Countries Next Generation Cancer Diagnostics Sales Volume and Growth Rate (2017-2028)

    • Figure Nordic Countries Next Generation Cancer Diagnostics Sales Value and Growth Rate (2017-2028)

    • Figure Spain Next Generation Cancer Diagnostics Sales Volume and Growth Rate (2017-2028)

    • Figure Spain Next Generation Cancer Diagnostics Sales Value and Growth Rate (2017-2028)

    • Figure Belgium Next Generation Cancer Diagnostics Sales Volume and Growth Rate (2017-2028)

    • Figure Belgium Next Generation Cancer Diagnostics Sales Value and Growth Rate (2017-2028)

    • Figure Poland Next Generation Cancer Diagnostics Sales Volume and Growth Rate (2017-2028)

    • Figure Poland Next Generation Cancer Diagnostics Sales Value and Growth Rate (2017-2028)

    • Figure Russia Next Generation Cancer Diagnostics Sales Volume and Growth Rate (2017-2028)

    • Figure Russia Next Generation Cancer Diagnostics Sales Value and Growth Rate (2017-2028)

    • Figure Turkey Next Generation Cancer Diagnostics Sales Volume and Growth Rate (2017-2028)

    • Figure Turkey Next Generation Cancer Diagnostics Sales Value and Growth Rate (2017-2028)

    • Table APAC Next Generation Cancer Diagnostics Sales Volume, by Type (2017-2028)

    • Table APAC Next Generation Cancer Diagnostics Sales Volume Share, by Type (2017-2028)

    • Figure APAC Next Generation Cancer Diagnostics Sales Volume Share, by Type (2017-2028)

    • Table APAC Next Generation Cancer Diagnostics Sales Volume, by Application (2017-2028)

    • Table APAC Next Generation Cancer Diagnostics Sales Volume Share, by Application (2017-2028)

    • Figure APAC Next Generation Cancer Diagnostics Sales Volume Share, by Application (2017-2028)

    • Figure China Next Generation Cancer Diagnostics Sales Volume and Growth Rate (2017-2028)

    • Figure China Next Generation Cancer Diagnostics Sales Value and Growth Rate (2017-2028)

    • Figure Japan Next Generation Cancer Diagnostics Sales Volume and Growth Rate (2017-2028)

    • Figure Japan Next Generation Cancer Diagnostics Sales Value and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Next Generation Cancer Diagnostics Sales Volume and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Next Generation Cancer Diagnostics Sales Value and Growth Rate (2017-2028)

    • Figure India Next Generation Cancer Diagnostics Sales Volume and Growth Rate (2017-2028)

    • Figure India Next Generation Cancer Diagnostics Sales Value and Growth Rate (2017-2028)

    • Figure ASEAN Countries Next Generation Cancer Diagnostics Sales Volume and Growth Rate (2017-2028)

    • Figure ASEAN Countries Next Generation Cancer Diagnostics Sales Value and Growth Rate (2017-2028)

    • Figure South Korea Next Generation Cancer Diagnostics Sales Volume and Growth Rate (2017-2028)

    • Figure South Korea Next Generation Cancer Diagnostics Sales Value and Growth Rate (2017-2028)

    • Table Latin America, Middle East and Africa Next Generation Cancer Diagnostics Sales Volume, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Next Generation Cancer Diagnostics Sales Volume Share, by Type (2017-2028)

    • Figure Latin America, Middle East and Africa Next Generation Cancer Diagnostics Sales Volume Share, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Next Generation Cancer Diagnostics Sales Volume, by Application (2017-2028)

    • Table Latin America, Middle East and Africa Next Generation Cancer Diagnostics Sales Volume Share, by Application (2017-2028)

    • Figure Latin America, Middle East and Africa Next Generation Cancer Diagnostics Sales Volume Share, by Application (2017-2028)

    • Figure GCC Countries Next Generation Cancer Diagnostics Sales Volume and Growth Rate (2017-2028)

    • Figure GCC Countries Next Generation Cancer Diagnostics Sales Value and Growth Rate (2017-2028)

    • Figure Brazil Next Generation Cancer Diagnostics Sales Volume and Growth Rate (2017-2028)

    • Figure Brazil Next Generation Cancer Diagnostics Sales Value and Growth Rate (2017-2028)

    • Figure Nigeria Next Generation Cancer Diagnostics Sales Volume and Growth Rate (2017-2028)

    • Figure Nigeria Next Generation Cancer Diagnostics Sales Value and Growth Rate (2017-2028)

    • Figure South Africa Next Generation Cancer Diagnostics Sales Volume and Growth Rate (2017-2028)

    • Figure South Africa Next Generation Cancer Diagnostics Sales Value and Growth Rate (2017-2028)

    • Figure Argentina Next Generation Cancer Diagnostics Sales Volume and Growth Rate (2017-2028)

    • Figure Argentina Next Generation Cancer Diagnostics Sales Value and Growth Rate (2017-2028)

    • Table Janssen Global Services Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Janssen Global Services Product Profiles, Application and Specification

    • Table Janssen Global Services Next Generation Cancer Diagnostics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Qiagen Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Qiagen Product Profiles, Application and Specification

    • Table Qiagen Next Generation Cancer Diagnostics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Sysmex Corporation Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Sysmex Corporation Product Profiles, Application and Specification

    • Table Sysmex Corporation Next Generation Cancer Diagnostics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table F Hoffmann-La Roche Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table F Hoffmann-La Roche Ltd Product Profiles, Application and Specification

    • Table F Hoffmann-La Roche Ltd Next Generation Cancer Diagnostics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Koninklijke Philips NV Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Koninklijke Philips NV Product Profiles, Application and Specification

    • Table Koninklijke Philips NV Next Generation Cancer Diagnostics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Agilent Technologies Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Agilent Technologies Product Profiles, Application and Specification

    • Table Agilent Technologies Next Generation Cancer Diagnostics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Abbott Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Abbott Product Profiles, Application and Specification

    • Table Abbott Next Generation Cancer Diagnostics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Cepheid Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Cepheid Product Profiles, Application and Specification

    • Table Cepheid Next Generation Cancer Diagnostics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Opko Health Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Opko Health Product Profiles, Application and Specification

    • Table Opko Health Next Generation Cancer Diagnostics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Thermo Fisher Scientific Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Thermo Fisher Scientific Product Profiles, Application and Specification

    • Table Thermo Fisher Scientific Next Generation Cancer Diagnostics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Almac Group Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Almac Group Product Profiles, Application and Specification

    • Table Almac Group Next Generation Cancer Diagnostics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Novartis AG Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Novartis AG Product Profiles, Application and Specification

    • Table Novartis AG Next Generation Cancer Diagnostics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Hologic Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Hologic Product Profiles, Application and Specification

    • Table Hologic Next Generation Cancer Diagnostics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Illumina Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Illumina Product Profiles, Application and Specification

    • Table Illumina Next Generation Cancer Diagnostics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Genomic Health Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Genomic Health Product Profiles, Application and Specification

    • Table Genomic Health Next Generation Cancer Diagnostics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Myriad Genetics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Myriad Genetics Product Profiles, Application and Specification

    • Table Myriad Genetics Next Generation Cancer Diagnostics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table GE Healthcare Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table GE Healthcare Product Profiles, Application and Specification

    • Table GE Healthcare Next Generation Cancer Diagnostics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table PerkinElmer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table PerkinElmer Product Profiles, Application and Specification

    • Table PerkinElmer Next Generation Cancer Diagnostics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.